Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets

OBJECTIVE: Investigate a combination of two clinically tested drugs, the NR2B antagonist Radiprodil and the A(2A) antagonist Tozadenant in the MPTP-treated marmoset model of Parkinson’s Disease (PD). BACKGROUND: In PD, there remains a need for the development of non-dopaminergic drugs to effectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Anne, Nicolas, Jean-Marie, Rose, Sarah, Jackson, Michael, Colman, Peter, Briône, Willy, Sciberras, David, Muglia, Pierandrea, Scheller, Dieter K., Citron, Martin, Downey, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576667/
https://www.ncbi.nlm.nih.gov/pubmed/28854243
http://dx.doi.org/10.1371/journal.pone.0182887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576667/
https://www.ncbi.nlm.nih.gov/pubmed/28854243
http://dx.doi.org/10.1371/journal.pone.0182887

Ejemplares similares